3-Aminoisobutyric Acid (sodium salt)
(Synonyms: β-Aminoisobutyric Acid, BAIBA) 目录号 : GC46584A neuropeptide with diverse biological activities
Cas No.:84796-61-2
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
3-Aminoisobutyric acid is a non-protein amino acid formed during thymine catabolism.1 It induces browning in primary adipocytes, increasing the expression of uncoupling protein 1 (UCP-1) and CIDEA when used at a concentration of 5 µM. It also increases the expression of PPARα in primary adipocytes and in mouse inguinal white adipose tissue (WAT) in vivo and increases β-oxidation in hepatocytes. Plasma levels of 3-aminoisobutyric acid are increased in mice following exercise and, when administered at a dose of 100 mg/kg per day, it decreases weight gain and body fat percentage without decreasing food intake or increasing energy expenditure, and improves glucose tolerance. Levels of 3-aminoisobutyric acid are elevated in the plasma, urine, and cerebrospinal fluid of patients with β-ureidopropionase deficiency, a disorder characterized by an inborn error of pyrimidine degradation.2
1.Roberts, L.D., BostrÖm, P., O'Sullivan, J.F., et al.β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factorsCell Metab.19(1)96-108(2014) 2.van Kuilenburg, A.B., Meinsma, R., Beke, E., et al.β-Ureidopropionase deficiency: An inborn error of pyrimidine degradation associated with neurological abnormalitiesHum. Mol. Genet.13(22)2793-2801(2004)
Cas No. | 84796-61-2 | SDF | |
别名 | β-Aminoisobutyric Acid, BAIBA | ||
Canonical SMILES | NCC(C)C(O)=O | ||
分子式 | C4H8NO2.Na | 分子量 | 125.1 |
溶解度 | DMSO: 10 mM | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 7.9936 mL | 39.968 mL | 79.9361 mL |
5 mM | 1.5987 mL | 7.9936 mL | 15.9872 mL |
10 mM | 0.7994 mL | 3.9968 mL | 7.9936 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。